These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 10995934)

  • 1. Immune tolerance induced by administration of donor-specific antigen and cyclophosphamide in rat fetal small bowel transplantation.
    Nakao M; Shima Y; Ogita K; Taguchi T; Suita S
    Transplant Proc; 2000 Sep; 32(6):1252. PubMed ID: 10995934
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined effect of donor-specific bone marrow transplantation via portal vein and FK506 on small bowel transplantation in the rat.
    Nakao A; Yagi T; Matsukawa H; Endo A; Okada Y; Sun DS; Sadamori H; Inagaki M; Matsuno T; Tanaka N
    Transplant Proc; 2000 Nov; 32(7):2011-2. PubMed ID: 11120044
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of antibodies to leukocyte function-associated antigen-1 and intercellular adhesion molecule-1 on fetal bowel allo- and xenotransplantation in mice.
    Yamataka A; Kato Y; Fujiwara T; Yagita H; Okumura K; Sunagawa M; Nozawa M; Miyano T
    Transplant Proc; 1996 Oct; 28(5):2494-5. PubMed ID: 8907919
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of different forms of recipient antigen and different routes of antigen administration in donor pretreatment for preventing graft-versus-host disease in rat small bowel transplantation.
    He G; Wang M; Xu H; Tian L; Yu J; Stepkowski SM; Kahan BD
    Transplant Proc; 1996 Oct; 28(5):2469. PubMed ID: 8907906
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of a new immunosuppressant, CAM, on small bowel transplantation in rats.
    Sawada H; Kaihara S; Egawa H; Inomata Y; Tanaka K; Yamaoka Y
    Transplant Proc; 1996 Oct; 28(5):2512-3. PubMed ID: 8907928
    [No Abstract]   [Full Text] [Related]  

  • 6. Small bowel transplantation in sensitized recipients: comparison with heart, kidney, and liver grafts.
    Murase N; Fujisaki S; Tanabe M; Tsamandas AC; Todo S; Starzl TE; Demetris AJ
    Transplant Proc; 1994 Jun; 26(3):1517-8. PubMed ID: 7518139
    [No Abstract]   [Full Text] [Related]  

  • 7. Leflunomide immunosuppression in rat small intestinal transplantation.
    Foster PF; Xiao F; Kociss K; Chong AS; Sankary HN; McChesney L; Cohn S; Williams JW
    Transplant Proc; 1994 Jun; 26(3):1599-600. PubMed ID: 8030053
    [No Abstract]   [Full Text] [Related]  

  • 8. Intraportal donor-specific transfusion given 24 hours before small bowel transplantation with cyclosporine and FK 506.
    Takara T; Tchervenkov JI; Guttman FM; Fecteau A; Rosenmann E
    Transplant Proc; 1994 Jun; 26(3):1622. PubMed ID: 7518150
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral leflunomide prevents small bowel allograft rejection in the rat.
    He G; McAlister VC; Lee TD; Bitter-Suermann H; Theal M; Wright J; MacDonald AS
    Transplant Proc; 1994 Jun; 26(3):1613. PubMed ID: 8030057
    [No Abstract]   [Full Text] [Related]  

  • 10. Intraportal injection of specific allogeneic cells can prolong neonatal intestinal free graft survival.
    Lee SK; Perez-Atayde A; Takeda T; Vacanti JP; Lund DP
    Transplant Proc; 1994 Jun; 26(3):1579-80. PubMed ID: 8030044
    [No Abstract]   [Full Text] [Related]  

  • 11. CD8+ host cells infiltrate the intestinal mucosa after allogeneic small bowel transplantation even in the absence of acute rejection.
    Nüssler NC; Cicalese L; Hoffman RA; Rastellini C; Neuhaus P; Simmons RL; Schraut WH
    Transplant Proc; 1996 Oct; 28(5):2456. PubMed ID: 8907898
    [No Abstract]   [Full Text] [Related]  

  • 12. Selective immunosuppression with FK 506, anti-IL-2R, and anti-ICAM-1 monoclonal antibodies: contrasting effects after liver and small bowel transplantation in rats.
    Otto C; Gasser M; Gassel HJ; Steger U; Timmermann W; Meyer D; Ulrichs K; Thiede A
    Transplant Proc; 1998 Aug; 30(5):2161-2. PubMed ID: 9723426
    [No Abstract]   [Full Text] [Related]  

  • 13. Immune tolerance induced by donor antigen and cyclophosphamide in rat fetal small bowel transplantation.
    Nakao M; Taguchi T; Ogita K; Nishimoto Y; Suita S
    Fukuoka Igaku Zasshi; 2005 Feb; 96(2):49-57. PubMed ID: 15852663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Tolerogenic effect" of the liver for a small bowel allograft.
    Meyer D; Otto C; Rummel C; Gassel HJ; Timmermann W; Ulrichs K; Thiede A
    Transpl Int; 2000; 13 Suppl 1():S123-6. PubMed ID: 11111977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cycloprodigiosin hydrochloride as an immunosuppressant in rat small bowel transplantation.
    Nakai K; Hamada Y; Kato Y; Yamamoto D; Hirata H; Hioki K
    Transplant Proc; 2000 Sep; 32(6):1324-5. PubMed ID: 10995968
    [No Abstract]   [Full Text] [Related]  

  • 16. Concomitant liver transplantation reduces the rate of chronic small bowel allograft rejection.
    Meyer D; Otto C; Gasser M; Gassel HJ; Timmermann W; Ulrichs K; Thiede A
    Transplant Proc; 2002 May; 34(3):1040-1. PubMed ID: 12034296
    [No Abstract]   [Full Text] [Related]  

  • 17. Tolerance: a study in long-term surviving animals after small bowel transplantation.
    Quijano Y; Redondo C; Correa C; Nuño J; Devesa M; Hervas PL; Candela A; Honrubia A; Moreno A; Sastre A; Morejon E; Antonio J; Sanroman L; Castanez JL; Vicente E
    Transplant Proc; 1998 Sep; 30(6):2573-4. PubMed ID: 9745494
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of short-term immunosuppressive therapy with FK 506 or CyA on the donor in small intestine allotransplantation in rats.
    Santiago SF; Fukuzawa M; Azuma T; Okada A
    Transplant Proc; 1992 Jun; 24(3):1189. PubMed ID: 1376520
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of rapamycin on orthotopic small bowel transplantation in the rat.
    Chen H; Wu J; Xu D; Aboujaoude M; Stepkowski S; Kahan B; Daloze P
    Transplant Proc; 1992 Jun; 24(3):1157-8. PubMed ID: 1604567
    [No Abstract]   [Full Text] [Related]  

  • 20. In vivo evidence for the Th1/Th2 paradigm: oral alloantigen-induced modulation of accelerated allograft rejection is associated with dense intragraft IL-4.
    Hancock WW; Sayegh MH; Carpenter CB
    Transplant Proc; 1992 Oct; 24(5):2313-4. PubMed ID: 1413074
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.